Upgrade to SI Premium - Free Trial

Boston Scientific (BSX) PT Raised to $28.50 at Evercore ISI; Revenue Beat was 'Remarkable'

April 27, 2017 12:00 PM
Evercore ISI raised its price target on Boston Scientific (NYSE: BSX) to $28.50 (from $26.50) while maintaining a Outperform rating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles